Entra Health Systems, an international applied health care technology company, announces the official US launch of the first FDA cleared and CE certified Bluetooth® blood glucose meter. The MyGlucoHealth meter, along with the MyGlucoHealth Network, form an integrated telemedicine platform supporting patients and healthcare professionals in the control and treatment of diabetes.
The MyGlucoHealth meter works in combination with a real-time online data collection network to upload and manage blood glucose readings using a mobile phone or PC computer. This eliminates the need for patients to maintain personal logbooks, thus improving data accuracy and removing the opportunity for incomplete or ‘manufactured’ readings.
The Bluetooth communication built-in to every meter instantly connects patients to a network of information and resources. Using the MyGlucoHealth Patient Analytics Portal, or regional sites throughout the world, patients securely transmit and evaluate their daily readings while communicating those same results to their families, caregiver, or diabetic care specialist. Direct, real-time data helps clarify and define treatment strategies and improve overall patient care.
“MyGlucoHealth is more than just an advanced meter, with rapid results,” said Richard Strobridge, Chief Executive Officer of Entra Health Systems.
“MyGlucoHealth is a comprehensive diabetes management tool that gives patients more direct control over their care and provides clear lines of communication with clinicians and caregivers. MyGlucoHealth monitors a patient’s day-to-day condition, while informing and motivating patients to follow a routine that leads to a healthier lifestyle. With testing results available in just 3 seconds, the smallest blood sample size of 0.3 microliters and automatic coding of test strips, there is no question the MyGlucoHealth meter is the most technically advanced diabetic patient care product on the market today.”
“MyGlucoHealth offers significant financial benefits to patients, clinicians as well as medical insurance providers,” said John Hendel, chairman of Entra Health Systems. “Studies demonstrate that diabetics who test regularly cost significantly less to care for than those who don’t test as required. Patients that test infrequently can cost up to 10 times more to care for, due to complications, emergency room visits, and hospitalization that can often be avoided.”
The MyGlucoHealth Network is engineered to provide tools for diabetics to better care for themselves. The key to MyGlucoHealth is technology that quietly monitors not just the testing results of patients, but also the patterns of their testing. Using this information and automated tools, the MyGlucoHealth Network can set up reminders to encourage patients to test more frequently, as well as to notify the patient’s family and caregivers when testing results exceed thresholds or fluctuate.
Source: Entra Health Systems